Privia Health Group, Inc. (NASDAQ:PRVA) Receives $25.07 Average Target Price from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVAGet Free Report) has received an average rating of “Buy” from the sixteen analysts that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $25.07.

PRVA has been the subject of several recent analyst reports. Barclays increased their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. KeyCorp began coverage on shares of Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Truist Financial raised their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, Robert W. Baird upped their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th.

Check Out Our Latest Research Report on PRVA

Privia Health Group Trading Up 2.3 %

Shares of NASDAQ PRVA opened at $21.56 on Tuesday. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $24.30. The company has a market cap of $2.59 billion, a PE ratio of 215.62, a P/E/G ratio of 5.26 and a beta of 0.76. The stock has a 50 day simple moving average of $18.96 and a 200-day simple moving average of $18.57.

Insider Buying and Selling

In other news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares in the company, valued at $4,583,763.50. This represents a 35.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 14.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Canada Pension Plan Investment Board acquired a new stake in Privia Health Group during the 2nd quarter worth about $26,000. Nisa Investment Advisors LLC boosted its holdings in shares of Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after purchasing an additional 930 shares during the period. GAMMA Investing LLC grew its position in Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares in the last quarter. Signaturefd LLC increased its stake in Privia Health Group by 46.3% in the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after buying an additional 626 shares during the period. Finally, Quarry LP lifted its position in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after buying an additional 2,533 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

(Get Free Report

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.